Detail of the clinical trial

Title of the trial Randomized comparison between two dose levels of daunorubicin and between one versus two cycles of induction therapy for adult patients with acute myeloid leukemia aged under 60 years.
EudraCT number 2013-003191-12
Protocol number TUD-2DAUNO-058
Sponsor Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
Indications Hemato-oncology
Diagnosis acute myeloid leukemia
Population in clinical trial Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2015
Date of approval by Institute (SÚKL) 20.8.2015
Date of approval by EC 16.9.2015
Date of initiation CT in ČR 21.3.2016
Date of ending CT in ČR 16.10.2020
Notice
Sites Fakultní nemocnice Brno, Interní hematologická a onkologická klinika, Jihlavská 20, 625 00 Brno

‹‹ Back to list